Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
- Written by PR Newswire
![]() |
GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed offering of $125 million aggregate principal amount of convertible senior notes due 2027 (the "notes"). The notes...
Read more: Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes